MedTrace Logo

Copeptin and Arterial Hypotension in Critically Ill Paediatric and Neonatal Intensive Care Patients

NCT03320967 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2019-07-05

No results posted yet for this study

Summary

Blood copeptin will be measured during the routine treatment of neonates, children and adolescents on the Intensive Care Unit of the University Children's Hospital Zurich at different time points (admission, 12, 24, 48, 96, 168 hours after admission). These values will be primarily analysed for their variability and their association with arterial hypotension. Blood samples will be drawn together with otherwise medically indicated blood withdrawals to avoid extra harm. Further, copeptin values will be compared to clinical and vital parameters, all of them open-label available during clinical routine. Copeptin's predictive value for patients' outcome will be analysed as secondary outcome.

Conditions

  • Arterial Hypotension in Critically Ill Neonatal and Pediatric Patients

Interventions

DIAGNOSTIC_TEST

Copeptin in plasma

Copeptin will be measured in EDTA-Plasma. Samples will be stored for batch analyses later.

Sponsors & Collaborators

  • Vincenzo Cannizzaro

    lead OTHER

Principal Investigators

  • Vinzenco Cannizzaro, MD, PhD · University Children's Hospital, Zurich

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-04
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03320967 on ClinicalTrials.gov